Literature DB >> 8166347

Seroepidemiology of amebiasis in Mexico.

A Caballero-Salcedo1, M Viveros-Rogel, B Salvatierra, R Tapia-Conyer, J Sepulveda-Amor, G Gutierrez, L Ortiz-Ortiz.   

Abstract

The presence of serum antibodies to Entamoeba histolytica was detected by indirect hemagglutination in a representative sample of the 32 federal entities of the Mexican Republic. This study was designed to include biologic, geographic, social, economic, and educational variables. The total percentage of positive sera was 8.41%. Seroprevalence varied with geographic zones, with the South Central, South Pacific, and Yucatan Peninsula areas showing the highest values (> or = 9%), and the North, Northeast, and Gulf of Mexico areas showing the lowest values (< or = 8.0%). Seroprevalence of anti-E. histolytica antibodies seemed to increase from the northern regions to the southern areas of Mexico. These results indicated that amebiasis is endemic in the Mexican Republic, with areas of high seroprevalence not related to climatic conditions. Exposure to infectious contact with E. histolytica occurred at all ages, with a higher frequency at school age.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166347     DOI: 10.4269/ajtmh.1994.50.412

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

1.  Evaluation of a rapid point-of-care fecal antigen detection test for Entamoeba histolytica.

Authors:  Poonum S Korpe; Blake R Stott; Forida Nazib; Mamun Kabir; Rashidul Haque; Joel F Herbein; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Anti-inflammatory defense mechanisms of Entamoeba histolytica.

Authors:  Raúl Silva-García; Guadalupe Rico-Rosillo
Journal:  Inflamm Res       Date:  2010-10-12       Impact factor: 4.575

4.  The invasiveness of Entamoeba histolytica - a continuing enigma.

Authors:  J P Ackers
Journal:  Clin Mol Pathol       Date:  1996-08

Review 5.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

6.  Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.

Authors:  Xiaoti Guo; Lisa Barroso; Steven M Becker; David M Lyerly; Thomas S Vedvick; Steven G Reed; William A Petri; Eric R Houpt
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 7.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

8.  Amebic liver abscess diagnosed by polymerase chain reaction in 14 returning travelers.

Authors:  Dorothée Vallois; Loïc Epelboin; Feriel Touafek; Denis Magne; Marc Thellier; François Bricaire; Eric Caumes
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

Review 9.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 10.  Amebic infection in humans.

Authors:  Gourdas Choudhuri; Murali Rangan
Journal:  Indian J Gastroenterol       Date:  2012-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.